Interviews

Charles Sansbury

2024-11-28

We play a key role in helping businesses overcome these challenges by providing reference architectures, such as open data lakehouses, to integrate disparate data sources. Once this foundation is in place, organizations can start applying models that generate real business value.

Joe Panetta

President & CEO

Biocom California

2024-11-27

I will continue as President Emeritus, focusing on our strategic global relationships, particularly in light of new regulations like the Biosecure Act, which may restrict collaborations with Chinese manufacturers. Biocom California is prepared to support members through this transition by strengthening ties with partners in regions like India and Korea.

William Humphries

CEO

Alcami Corporation

2024-11-27

Alcami is a U.S. contract development and manufacturing organization (CDMO), offering integrated services in laboratory testing, drug product manufacturing, and cGMP pharmaceutical storage and support.

Quentin Blackford

President & CEO

iRhythm Technologies

2024-11-27

Our key objective for 2025 is to work collaboratively with the FDA to address their concerns and establish clear standards for this emerging industry. Beyond regulatory efforts, we are focused on expanding into primary care settings, where the potential for early detection and treatment is significant.

Paul Garofolo

CEO & Co-Founder

Locus Biosciences

2024-11-27

Locus Biosciences is a clinical-stage biotechnology company developing precision biotherapeutics using engineered bacteriophage technology to target and eliminate specific pathogenic bacteria.

Trevor Martin

CEO

Mammoth Biosciences

2024-11-27

Mammoth Biosciences is a biotechnology company focused on developing in vivo gene-editing therapeutics using proprietary ultracompact CRISPR systems to create potential long-term curative therapies for life-threatening and debilitating diseases.

Bhaskar Sambasivan

CEO

Saama

2024-11-27

Our primary goal is to support the industry’s shift to embrace AI by listening, engaging, and continuously investing. Listening involves gathering feedback from customers, partners, and industry stakeholders to shape a relevant and adaptable platform. Engaging means being responsive to client needs, showing agility, and solving real-world problems effectively.

Patrick Mooney& Malik Kahook

CEO & M.D., Co-founder & Executive Chair of the Board

SpyGlass Pharma

2024-11-27

The industry is definitely close-knit, which can be both a strength and a weakness. The key is balancing familiarity with fresh ideas - that is what will drive our next big breakthroughs. Our clinical team is a perfect example: it includes both longtime collaborators and people working with us for the first time. This blend of experience and new talent is making us stronger and more innovative.

Jim Lassiter

Vice-President/GM ThermoSafe

Sonoco

2024-11-27

Sonoco, a company with over 125 years of history, welcomed ThermoSafe into its portfolio in 2011. To strengthen ThermoSafe's strategic presence in Europe, Sonoco acquired Laminar in 2015. In the years that followed, ThermoSafe achieved groundbreaking advancements in product development, becoming the first packaging provider to offer a truly comprehensive range of solutions across sizes, temperature ranges and applications.

Tony Pialis

Founder & CEO

Alphawave Semi

2024-11-27

One of the most significant factors that will impact next year is the outcome of the U.S. election, which I believe will have a substantial influence on the timeline for the further separation of the U.S. and Chinese economies. In addition to this, continued investment in semiconductors and the regulation of AI are macro-level geopolitical factors that could greatly affect the future of our industry. As we look forward to 2025, I anticipate these trends will continue to shape the landscape, with the upcoming U.S. election playing a particularly crucial role.

Pagina 3 din 140